Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;29(5):1406-1416.
doi: 10.1038/s41380-024-02419-6. Epub 2024 Feb 23.

(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice

Affiliations

(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice

Rei Yokoyama et al. Mol Psychiatry. 2024 May.

Abstract

Chronic social isolation increases the risk of mental health problems, including cognitive impairments and depression. While subanesthetic ketamine is considered effective for cognitive impairments in patients with depression, the neural mechanisms underlying its effects are not well understood. Here we identified unique activation of the anterior insular cortex (aIC) as a characteristic feature in brain-wide regions of mice reared in social isolation and treated with (R)-ketamine, a ketamine enantiomer. Using fiber photometry recording on freely moving mice, we found that social isolation attenuates aIC neuronal activation upon social contact and that (R)-ketamine, but not (S)-ketamine, is able to counteracts this reduction. (R)-ketamine facilitated social cognition in social isolation-reared mice during the social memory test. aIC inactivation offset the effect of (R)-ketamine on social memory. Our results suggest that (R)-ketamine has promising potential as an effective intervention for social cognitive deficits by restoring aIC function.

PubMed Disclaimer

Conflict of interest statement

KH is the inventor of filed patent applications on “The use of R-ketamine in the treatment of psychiatric diseases,” “(S)-norketamine and salt thereof as pharmaceutical,” “R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder,” “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases,” and “R-ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. KH has also received speakers’ honoraria, consultant fees, or research support from Abbott, Boehringer Ingelheim, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Dainippon-Sumitomo, Taisho, Otsuka, Murakami Farm and Perception Neuroscience. All other authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1. Insular cortex activation as a key feature in (R)-ketamine-treated brain.
a Experimental timeline and schematic of the social isolation rearing and brain-wide IEG mapping after the forced swim test using Arc-dVenus mice. FST, forced swim test. b Immobility time of social isolation-reared Arc-dVenus mice treated with indicated drugs in the FST (for saline, 10 mg/kg (R)-ketamine, and 10 mg/kg (S)-ketamine; n = 5, in each group). Statistical analysis was performed using Levene’s test and one-way ANOVA, followed by Tukey’s multiple comparison test. Levene’s test: p = 0.223; one-way ANOVA: F(2, 12) = 8.129, p = 0.0059. *p < 0.05, **p < 0.01. (R)-ket, (R)-ketamine; (S)-ket, (S)-ketamine. c The box-whisker plot (center: median; box: 25–75th percentiles; whiskers: minimum to maximum) displays the z-score values for the number of dVenus-positive cells in each brain region. The abbreviations for the brain areas are provided in table S1. d The formula shows the transformation of classifier weights into corresponding activation patterns (left). The absolute values of the activation patterns of brain regions are plotted in the two indicated classifications. e Representative coronal images of the anterior insular cortex (aIC) of Arc-dVenus mice treated with indicated drugs (top). Scale bar, 500 µm. The anteroposterior distribution of dVenus-positive cells in the IC is shown in the bottom panel. mIC, the middle IC; pIC, the posterior IC. Statistical analysis was performed using Two-way ANOVA, followed by Tukey’s multiple comparison test: spatial distribution, F(9, 120) = 4.378, p < 0.0001; treatment, F(2, 120) = 14.12, p < 0.001; interaction, F(18, 120) = 1.191, p = 0.2791. **p < 0.01, ***p < 0.001, ****p < 0.0001. Data are presented as the mean ± standard error of the mean (s.e.m.).
Fig. 2
Fig. 2. Attenuation of (R)-ketamine’s effect on immobility time via aIC inhibition.
a Experimental timeline and schematic of chemogenetic manipulation of the aIC in social isolation-reared mice and a schematic and representative image illustrating the selective transduction of hM4Di-mCherry at the injection site (highlighted in red). CNO, clozapine-N-oxide. b Immobility time of hM4Di-mCherry-expressing mice treated with 10 mg/kg (R)-ketamine or 20 mg/kg (S)-ketamine in the FST. Statistical analysis was performed using Levene’s test and one-way ANOVA, followed by Bonferroni’s multiple comparison test. Levene’s test: p = 0.153 (vehicle), p = 0.012 (CNO); one-way ANOVA: Vehicle, F(2, 47) = 6.198, p = 0.0041; CNO, F(2, 43) = 6.044, p = 0.0049. *p < 0.05, **p < 0.01. c Immobility time of hM3Dq-mCherry- or mCherry-expressing mice treated with vehicle or CNO in the FST. The number in parentheses indicates the number of mice used in the experiment. Statistical analysis was performed using Levene’s test and unpaired t test. Levene’s test: p = 0.744 (mCherry), p = 0.828 (hM3Dq). *p < 0.05. Data are presented as the mean ± s.e.m.
Fig. 3
Fig. 3. Boost of aIC neuronal responses to social investigation by (R)-ketamine.
a Experimental timeline and schematic of fiber photometry recording in social isolation- or group- reared mice during the three-chamber test. Neuronal activity of the aIC in social isolation-reared mice was observed during nonsequential interactions with a novel mouse or object in the 1st-3-chamber test with saline treatment (b, d, and f) and the 2nd-3-chamber test with drug treatment (c, e, and g for saline, 20 mg/kg (R)-ketamine, and 20 mg/kg (S)-ketamine; n = 5, 7, and 7, respectively). The right graphs show the quantification of social (orange) or object (gray) contact-evoked normalized GCaMP6f signals (mean evoked z-score of 0‒3 s at post-contact subtracted by the mean baseline z-score of −3‒0 s at pre-contact). Statistical analysis was performed using paired t test. *p < 0.05. Neuronal activity of the aIC in group-reared mice was observed in nonsequential interactions with a novel mouse or object in the 1st-3-chamber test (h) and 2nd-3-chamber test (i) with saline treatment (n = 7). The right graphs show the quantification of social (orange) or object (gray) contact-evoked normalized GCaMP6f signals (mean evoked z-score of 0‒3 s at post-contact subtracted by the mean baseline z-score of −3–0 s at pre-contact). Dashed lines indicate the onset of contact. Statistical analysis was performed using paired t test. *p < 0.05. Data are presented as the mean ± s.e.m.
Fig. 4
Fig. 4. Restoration of social cognitive deficits through (R)-ketamine-induced activation of the aIC.
a Experimental timeline and schematic of the social memory test using social isolation reared-mice with or without chemogenetic aIC inhibition and representative image of hM4Di-mCherry transduction at the injection site (highlighted in red). b Difference of investigation time to a familiar mouse between 1st trial and indicated trial (2nd to 4th trial) and to a novel mouse (5th trial) in the 1st social memory test 24 h after vehicle and saline treatments. ce Difference of investigation time to a familiar mouse between 6th trial and indicated trial (2nd to 4th trial) and to a novel mouse (10th trial) in the 2nd social memory test 24 h after vehicle and saline or 20 mg/kg (R)-ketamine treatments (for saline and (R)-ketamine; n = 14 and 16, respectively). Statistical analysis was performed using two-way repeated measured ANOVA, followed by Holm-Sidak multiple comparison test (c): time, F(4, 112) = 7.023, p < 0.0001; treatment, F(1, 28) = 1.57, p = 0.2206; interaction, F(4, 112) = 3.36, p = 0.0123, and using Levene’s test and unpaired t test (d, e). Levenes test: p = 0.207 (d), p = 0.179 (e); unpaired t test, *p < 0.05. f Immobility time of hM4Di-mCherry-expressing mice in the FST 48 h after drug treatments. Statistical analysis was performed using Levene’s test and unpaired t test (f). Levene’s test: p = 0.707; unpaired t test, *p < 0.05. g Difference of investigation time to a familiar mouse between 1st trial and indicated trial (2nd to 4th trial) and to a novel mouse (5th trial) in the 1st social memory test 24 h after vehicle and saline treatments. hj Difference of investigation time to a familiar mouse between 6th trial and indicated trial (2nd to 4th trial) and to a novel mouse (10th trial) in the 2nd social memory test 24 h after CNO and saline or 20 mg/kg (R)-ketamine treatments (for saline and (R)-ketamine; n = 15 and 16, respectively). Statistical analysis was performed using two-way repeated measured ANOVA: time, F(4, 116) = 15.03, p < 0.0001; treatment, F(1, 29) = 0.004067, p = 0.9496; interaction, F(4, 116) = 1.352, p = 0.2550, and using Levene’s test and unpaired t test (i, j). Levene’s test: p = 0.276 (i), p = 0.221 (j); unpaired t test, *p < 0.05. k Immobility time of hM4Di-mCherry-expressing mice in the FST 48 h after drug treatments. Statistical analysis was performed using Levene’s test and unpaired t test. Levene’s test: p = 0.441. Black lines, mouse treated with saline in both 1st and 2nd social memory test; Orange line, mouse treated with saline in 1st and (R)-ketamine in 2nd social memory test. Data are presented as the mean ± s.e.m.

References

    1. Cacioppo JT, Hawkey LC. Perceived social isolation and cognition. Trends Cogn Sci. 2009;13:447–54. doi: 10.1016/j.tics.2009.06.005. - DOI - PMC - PubMed
    1. Beutel ME, Klein EM, Brahler E, Reiner I, Junger C, Michal M, et al. Loneliness in the general population: prevalence, determinants and relations to mental health. BMC Psychiatry. 2017;17:97. doi: 10.1186/s12888-017-1262-x. - DOI - PMC - PubMed
    1. Kato TA, Kanba S, Teo AR. Hikikomori: multidimensional understanding, assessment, and future international perspectives. Psychiatry Clin Neurosci. 2019;73:427–40. doi: 10.1111/pcn.12895. - DOI - PubMed
    1. Loades ME, Chatburn E, Higson-Sweeney N, Reynolds S, Shafran R, Brigden A, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59:1218–39. doi: 10.1016/j.jaac.2020.05.009. - DOI - PMC - PubMed
    1. Nelson CA, Zeanah CH, Fox NA, Marshall PJ, Smyke AT, Guthrie D. Cognitive recovery in socially deprived young children: the Bucharest early intervention project. Science. 2007;318:1937–40. doi: 10.1126/science.1143921. - DOI - PubMed

LinkOut - more resources